India  

Johnson & Johnson

American multinational pharmaceutical and consumer goods corporation

Johnson & Johnson    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Johnson & Johnson: American multinational pharmaceutical and consumer goods corporation
Johnson & Johnson (J&J) is an American multinational, pharmaceutical, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 40 on the 2023 Fortune 500 list of the largest United States corporations. In 2023, the company was ranked 40th in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 130,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato.

0
shares
ShareTweetSavePostSend
 

You Might Like


After court win to make baby powder, J&J gives up licence

Three years since ceasing production of its talc-based powders in the US and Canada, pharmaceutical giant Johnson and Johnson recently surrendered its licence to manufacture baby powder in its Mumbai..
IndiaTimes - Published

Johnson & Johnson agrees to pay $8.9bn to settle claims that talc caused cancer

johnson & johnson agrees to pay $8.9bn to settle claims that talc caused cancer
Johnson & Johnson (J&J) has agreed to pay almost $9bn (£7.2bn) to settle tens of thousands of lawsuits alleging its talc caused cancer.
Sky News - Published

Johnson & Johnson’s set to lose patent on key TB drug in July

In one of the most-watched patent cases in recent times, the Indian Patent Office on Thursday rejected American giant Johnson & Johnson’s (J&J) attempt to extend its monopoly on life-saving TB drug..
IndiaTimes - Published

HC quashes J&J baby powder manufacture ban over FDA test delay


IndiaTimes - Published

Make, but don't sell: HC on J&J powder

The Bombay HC on Wednesday ordered for fresh testing of Johnson & Johnson baby powder samples and permitted the company to manufacture the product but to not sell it, as per the Maharashtra government..
IndiaTimes - Published

Maharashtra FDA cancels Johnson & Johnson baby powder licence over poor quality

The judgment was made after the Central Drugs Laboratory in Kolkata agreed with the Maharashtra FDA's 2019 report deeming the goods sub-standard.
DNA - Published

Johnson & Johnson to end global sales of talc-based baby powder

johnson & johnson to end global sales of talc-based baby powder
Johnson & Johnson has announced it will stop selling talc-based baby powder globally in 2023, more than two years after it ended US sales due to thousands of consumer safety lawsuits.
Sky News - Published

Opioid epidemic: Native American tribes reach settlements of $590m with J&J and three distributors

opioid epidemic: native american tribes reach settlements of $590m with j&j and three distributors
Native American tribes have reached settlements of $590m (£436m) with a pharmaceutical company and three distribution firms over the toll of opioids.
Sky News - Published

India set to get first J&J Covid vaccine doses in October, says source

India expects to get its first Johnson & Johnson Covid-19 vaccine doses from next month, filled and finished in India by a partner of the US drugmaker, a source with knowledge of the matter told..
IndiaTimes - Published

‘J&J should prioritise supply of locally-made Covid-19 jabs to India’


IndiaTimes - Published

Johnson & Johnson's single-shot vaccine likely to be rolled out in India by October

Johnson & Johnson's single-shot vaccine was the fifth vaccine to get Emergency Use Approval for use in India by Drug Controller General on August 7.
DNA - Published

Johnson and Johnson seeks nod to study Covid-19 vaccine among kids in India


IndiaTimes - Published

Covid-19: Johnson & Johnson seeks approval to conduct vaccine trials for 12-17 age group

Johnson & Johnson has submitted an application to the central drugs standard control organisation (CDSCO) to conduct a study of its Covid-19 vaccine in India in adolescents aged 12-17 years.
IndiaTimes - Published

Johnson & Johnson's single-dose Covid vax gets emergency use nod


IndiaTimes - Published Also reported by •DNA

Johnson and Johnson’s Covid-19 vaccine gets nod for emergency use in India

India has approved Johnson & Johnson's single-dose CoviD-19 vaccine for emergency use on Saturday, health minister Mansukh Mandaviya said in a tweet. This will further boost the country's collective..
IndiaTimes - Published Also reported by •DNA

Johnson & Johnson applies for Emergency Use Authorization of its single-dose Covid vaccine in India

Johnson & Johnson has applied for Emergency Use Authorization (EUA) of its single-dose Covid-19 vaccine in India, the global healthcare major said on Friday.
IndiaTimes - Published Also reported by •DNA

J&J withdraws plea to hold vaccine trials as govt relaxes norms


IndiaTimes - Published

'J&J withdraws proposal for speedy vaccine approval in India'


IndiaTimes - Published

Ben Crump Sues J&J Over 'Cancerous' Talcum Powder Targeted at Black Women

Ben Crump is suing Johnson & Johnson for allegedly targeting Black women with a product he says has been linked to cancer -- and it sounds like they're going class action with this. The civil rights..
TMZ.com - Published

Indemnity issue holds up J&J, Pfizer and Moderna jabs


IndiaTimes - Published

Covid-19: Wrong injection technique could also be leading to clots

A new study shows that wrong injection technique could be one of the reasons behind clotting following inoculation by adeno virus-based Covid vaccines, which include AstraZeneca, J&J and Sputnik jabs...
IndiaTimes - Published

Covid-19: Govt talking to J&J over single-dose jab

The government is in talks with Johnson & Johnson regarding their single-dose vaccine and as per the plan, this vaccine will also be produced by Hyderabad's Biological E, NITI Aayog member-health Dr V..
IndiaTimes - Published

India to get Johnson & Johnson's single-dose COVID-19 vaccine soon?

Appreciating the Janssen vaccine, Dr VK Paul said, "It is a good single-dose vaccine. Single doses can be used to complete the full course."
DNA - Published

Discussions on to speed up vaccine delivery: J&J


IndiaTimes - Published

J&J explores ways to speed up delivery of its Covid-19 vaccine in India

Johnson & Johnson (J&J) said on Tuesday it was in talks with the Indian government to explore ways to speed up delivery of its single-shot Covid-19 vaccine in the country. The Economic Times newspaper..
IndiaTimes - Published

Johnson & Johnson COVID-19 vaccine likely to be available in India by July - price and other details here

The efficacy of the vaccine developed by Johnson and Johnson is 66.3% for mild to moderate COVID-19 and 76.3% for severe to critical infection.
DNA - Published

Moderna offers to sell booster shots from January; indemnity-waiver talks on

US vaccine maker Moderna has offered to sell booster doses of its Covid vaccine to India, from January 2022 even as the government continues to hold negotiations with Moderna and J&J on the indemnity..
IndiaTimes - Published

India in talks with Pfizer, J&J, Moderna for local manufacturing of COVID vaccines: Harsh Vardhan Shringla

Last month saw India getting the first batches of Suptink V vaccines, which will be also produced by Indian companies.
DNA - Published

US Supreme Court rejects Johnson & Johnson appeal of $2bn talc verdict

us supreme court rejects johnson & johnson appeal of $2bn talc verdict
The US Supreme Court has declined to hear Johnson & Johnson's appeal against a $2.12bn (£1.5bn) damages award to women who say they developed ovarian cancer from using the company's talc products.
Sky News - Published

How does the newly-approved Johnson & Johnson COVID vaccine work - and how does it compare?

how does the newly-approved johnson & johnson covid vaccine work - and how does it compare?
The Johnson & Johnson (J&J) vaccine is the fourth coronavirus jab approved for use in the UK.
Sky News - Published

Johnson & Johnson single-dose vaccine approved for use in the UK

The Johnson & Johnson single-dose coronavirus vaccine has been approved for use in the UK, the medicines regulator has said.
Sky News - Published

Govt looking into securing part of Johnson & Johnson vaccines for Indian market: Sources


IndiaTimes - Published

Anti-Vaxxer Steals COVID Vaccine Vials in Bizarre Confrontation

An anti-vaxxer has been going around stealing vials of the Johnson & Johnson COVID vaccine, proclaiming it poisonous and urging people to turn their backs on it. It's a bizarre story. A guy named..
TMZ.com - Published

US panel recommends resuming Johnson & Johnson COVID-19 vaccine

us panel recommends resuming johnson & johnson covid-19 vaccine
A US medical panel has recommended resuming the use of the Johnson & Johnson COVID-19 vaccine.
Sky News - Published

Johnson & Johnson's Covid vaccine expected to be imported by June-July: Science and technology ministry


IndiaTimes - Published

Johnson & Johnson COVID vaccine could be linked to rare blood clots, EU regulator says

The European Medicines Agency says it has found a possible link between the Johnson & Johnson COVID vaccine and very rare cases of unusual blood clots.
Sky News - Published

India paves way for foreign Covid-19 vaccines: Side effects, risks of Pfizer, Moderna, Sputnik, J&J


IndiaTimes - Published

Pfizer, J&J vaccine rollout in India could take a few months

US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines..
IndiaTimes - Published

Covid-19 vaccine: Pfizer, J&J entry could still be months away

US pharma biggies Pfizer, Johnson & Johnson and Moderna could be amongst the potential gainers of the government’s decision to fast-track approvals for foreign-produced Covid-19 vaccines. While..
IndiaTimes - Published

India ​seeks imports of Covid vaccines as cases soar

India is to fast-track emergency approvals for Covid-19 vaccines that have been authorised by Western countries and Japan, paving the way for possible imports of Pfizer, Johnson & Johnson, and Moderna..
IndiaTimes - Published

European rollout of Johnson & Johnson COVID jab delayed as US officials investigate clots

The rollout of the Johnson & Johnson COVID vaccine across Europe has been delayed, while US officials have recommended a "pause" in the use of the jab as reports of blood clots are investigated.
Sky News - Published

US recommends 'pause' to Johnson & Johnson jab rollout over blood clot fears

us recommends 'pause' to johnson & johnson jab rollout over blood clot fears
The US Food and Drug Administration has recommended a "pause" to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.
Sky News - Published

J&J in talks to start bridging clinical study


IndiaTimes - Published

EU regulator reviewing possible links between Johnson & Johnson jab and blood clots

Europe's drugs regulator is reviewing possible links between blood clots and Johnson & Johnson's coronavirus vaccine.
Sky News - Published

Johnson & Johnson says in talks with Indian govt for trial of single-dose vaccine


IndiaTimes - Published


 Page 1  〉